loading page

Nasal Nitric Oxide May Not Differentiate Primary Ciliary Dyskinesia from Certain Primary Immunodeficiencies
  • Jessica Saunders,
  • Michael O'Connor,
  • Evans Machogu
Jessica Saunders
Indiana University School of Medicine

Corresponding Author:[email protected]

Author Profile
Michael O'Connor
Vanderbilt University Medical Center
Author Profile
Evans Machogu
Indiana University School of Medicine
Author Profile

Abstract

The diagnosis of primary ciliary dyskinesia (PCD) is made through a combination of clinical features supported by a panel of diagnostic tests. Our cases highlight the similarities in the clinical presentation of patients with the specific immunodeficiency activated phosphatidylinositol 3-kinase delta syndrome 1 (APDS1 or PIK3CD) and PCD. We highlight the importance of repeating nasal nitric oxide testing (nNO) when PCD has not been confirmed by genetic or ciliary electron micrograph (EM) analysis in the setting of an expanded suppurative lung disease differential that includes considerations for immunodeficiency as well as PCD.
10 Feb 2022Submitted to Pediatric Pulmonology
12 Feb 2022Submission Checks Completed
12 Feb 2022Assigned to Editor
24 Feb 2022Reviewer(s) Assigned
24 Feb 2022Review(s) Completed, Editorial Evaluation Pending
11 Mar 2022Editorial Decision: Revise Major
01 Apr 20221st Revision Received
04 Apr 2022Submission Checks Completed
04 Apr 2022Assigned to Editor
04 Apr 2022Reviewer(s) Assigned
19 Apr 2022Review(s) Completed, Editorial Evaluation Pending
10 May 2022Editorial Decision: Revise Minor
13 May 20222nd Revision Received
14 May 2022Assigned to Editor
14 May 2022Submission Checks Completed
14 May 2022Reviewer(s) Assigned
14 May 2022Review(s) Completed, Editorial Evaluation Pending
14 May 2022Editorial Decision: Accept
02 Jun 2022Published in Pediatric Pulmonology. 10.1002/ppul.25989